ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
96,859.09
-0.36%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.445
0.00%
Brent Oil
72.72
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Terns Pharmaceuticals Inc (TERN) 銘柄情報

Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc (TERN)

Tern Plc
5.86
-0.19
(-3.14%)
終了 12月22日 6:00AM
15分遅延
5.80
-0.06
(-1.02%)
取引時間後: 9:58AM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
5.80
買値
5.80
売値
9.74
出来高
4,750,011
5.785 日の範囲 6.13
4.32 52 週間の範囲 11.40
時価総額
492.645M
前日終値
6.05
始値
5.90
時刻
397
@
5.8
(formt)
最終取引時間
財務取引量
US$ 28,191,105
VWAP
5.935
平均取引量 (3 か月)
1,534,195
発行済株式数
84,938,855
配当利回り
-
PER
-5.53
1 株当たり利益 (EPS)
-1.06
歳入
-
純利益
-90.21M

Terns Pharmaceuticals Inc について

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.ternspharma.com
本社
Wilmington, Delaware, USA
設立
-
Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TERN. The last closing price for Terns Pharmaceuticals was US$6.05. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of US$ 4.32 to US$ 11.40.

Terns Pharmaceuticals currently has 84,938,855 shares in issue. The market capitalisation of Terns Pharmaceuticals is US$513.88 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.53.

TERN 最新ニュース

その他のニュース

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月17日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月10日
Edgar (US Regulatory)

Form 8-K - Current report

2024年12月3日
Edgar (US Regulatory)

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

Compelling molecular responses starting at lowest dose level in heavily pre-treated patients with high baseline BCR-ABL transcript levels Encouraging safety profile with no dose limiting...

2024年12月3日
GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio...

2024年12月3日
GlobeNewswire Inc.

Form 8-K - Current report

2024年11月19日
Edgar (US Regulatory)

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

FOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

2024年11月19日
GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans

2024年11月13日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月13日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月13日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.89-13.30343796716.697.145.4623321186.31201229CS
40.091.57618213665.717.465.4619406866.41388458CS
12-3.08-34.68468468478.8895.4615341956.82826298CS
26-1.53-20.87312414737.3311.45.4617002107.99905144CS
52-0.63-9.797822706076.4311.44.3212975227.50192044CS
156-0.06-1.023890784985.8614.04351.456851487.40471726CS
260-11.15-65.781710914516.9528.361.455535367.8025733CS

TERN - Frequently Asked Questions (FAQ)

What is the current Terns Pharmaceuticals share price?
The current share price of Terns Pharmaceuticals is US$ 5.80
How many Terns Pharmaceuticals shares are in issue?
Terns Pharmaceuticals has 84,938,855 shares in issue
What is the market cap of Terns Pharmaceuticals?
The market capitalisation of Terns Pharmaceuticals is USD 513.88M
What is the 1 year trading range for Terns Pharmaceuticals share price?
Terns Pharmaceuticals has traded in the range of US$ 4.32 to US$ 11.40 during the past year
What is the PE ratio of Terns Pharmaceuticals?
The price to earnings ratio of Terns Pharmaceuticals is -5.53
What is the reporting currency for Terns Pharmaceuticals?
Terns Pharmaceuticals reports financial results in USD
What is the latest annual profit for Terns Pharmaceuticals?
The latest annual profit of Terns Pharmaceuticals is USD -90.21M
What is the registered address of Terns Pharmaceuticals?
The registered address for Terns Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Terns Pharmaceuticals website address?
The website address for Terns Pharmaceuticals is www.ternspharma.com
Which industry sector does Terns Pharmaceuticals operate in?
Terns Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

議論

フィード全体を表示

最近閲覧した銘柄

NASDAQ
TERN
Terns Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有